GSK Annual Report 2011 243 Overview 02 Strategic review 10 Financial review & risk 51 Governance & remuneration 78 Financial statements 134 Shareholder information 222 Corporate Responsibility Report Taxation We will publish our Corporate Responsibility Report 2011 online General information concerning the UK and US tax effects of in March 2012.
This will outline GSKs approach and share ownership is set out on pages 245 to 246 Taxation performance on corporate responsibility areas, including access information for shareholders.
to healthcare, research and business ethics, environmental Internet sustainability and community investment.
Information about the company, including details of the share Nature of trading market price, is available on our website at www.
Information The following tables set out, for the periods indicated, the high made available on the website does not constitute part of this and low middle market closing quotations in pence for the shares Annual Report.
on the London Stock Exchange, and the high and low closing Annual General Meeting 2012 prices in US dollars for the ADS on the NYSE.
3 May 2012 Pence per share The Queen Elizabeth II Conference Centre Ordinary Shares High Low Broad Sanctuary, Westminster, London SW1P 3EE Quarter ended 31 March 2012 1497 1387 February 2012 1440 1387 The AGM is the companys principal forum for communication January 2012 1497 1410 with private shareholders.
In addition to the formal business, December 2011 1474 1400 there will be a presentation by the CEO on the performance of November 2011 1406 1329 the Group and its future development.
There will be an October 2011 1401 1312 opportunity for questions to be asked to the Board.
Chairmen of September 2011 1349 1265 the Boards Committees will take questions relating to those Quarter ended 31 December 2011 1474 1312 Committees.
Quarter ended 30 September 2011 1385 1205 Investors holding shares through a nominee service should arrange Quarter ended 30 June 2011 1349 1201 with that nominee service to be appointed as a proxy in respect of Quarter ended 31 March 2011 1270 1128 their shareholding in order to attend and vote at the meeting.
Quarter ended 31 December 2010 1319 1212 Quarter ended 30 September 2010 1290 1095 ADR holders wishing to attend the meeting must obtain a proxy Quarter ended 30 June 2010 1281 1119 from The Bank of New York Mellon.
This will enable them to Quarter ended 31 March 2010 1340 1196 attend and vote on the business to be transacted.
ADR holders Year ended 31 December 2009 1334 987 may instruct The Bank of New York Mellon as to the way in which Year ended 31 December 2008 1385 995 the shares represented by their ADR should be voted by Year ended 31 December 2007 1493 1160 completing and returning the voting card provided by the bank.
Documents on display US dollars per ADS ADS The Articles of Association of the company and other documents High Low referred to in this Annual Report are available for inspection at Quarter ended 31 March 2012 46.35 43.73 the Companys registered ofce and on our website.
February 2012 45.43 44.26 January 2012 46.35 43.73 Exchange controls and other limitations affecting December 2011 45.74 43.91 security holders November 2011 45.06 41.50 Other than certain economic sanctions which may be in place October 2011 45.00 40.53 from time to time, there are currently no UK laws, decrees or September 2011 42.61 40.31 regulations restricting the import or export of capital or affecting Quarter ended 31 December 2011 45.74 40.53 the remittance of dividends or other payments to holders of the Quarter ended 30 September 2011 44.91 38.84 companys shares who are non-residents of the UK.
Similarly, Quarter ended 30 June 2011 43.74 38.78 other than certain economic sanctions which may be in force Quarter ended 31 March 2011 39.86 36.33 from time to time, there are no limitations relating only to Quarter ended 31 December 2010 41.86 38.28 non-residents of the UK under English law or the companys Quarter ended 30 September 2010 40.47 33.78 Articles of Association on the right to be a holder of, and to vote Quarter ended 30 June 2010 39.57 32.34 in respect of, the companys shares.
Quarter ended 31 March 2010 42.97 37.03 Year ended 31 December 2009 42.91 27.27 Duplicate publications Year ended 31 December 2008 54.36 32.02 Please contact our registrars if you receive duplicate copies of this, Year ended 31 December 2007 59.35 47.87 or any other, GSK publication.
